Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Short Course: Digital Health Technologies for Combination Products and Beyond: Development and Regulation

October 24-26, 2016, DIA Combination Products Conference 2016: Current, Evolving, and Future Pathways

Wade Ackerman and Christina Kuhn taught the short course “Digital Health Technologies for Combination Products and Beyond: Development and Regulation” at DIA’s Combination Products 2016 conference. When it comes to the regulatory path to market for digital health technologies that touch upon drug products, much attention has been paid to FDA’s device center, but there has been less focus on the role of FDA’s drug center. This course looked at FDA’s evolving regulatory approach to mobile medical apps, clinical decision support software, wearables, and other digital health products that implicate pharmaceuticals or traditional devices.

DIA is a leading professional community for the health care product development industry, dedicated to providing a neutral and transparent forum for the exchange of ideas and collaborations to advance global scientific and medical innovations.

Share this article: